Natera (NTRA) Q2 2025 Earnings Call August 07, 2025 04:30 PM ET Company ParticipantsMike Brophy - CFOSteve Chapman - CEO & DirectorSolomon Moshkevich - President - Clinical DiagnosticsAlexey Aleshin - GM - Oncology and ECD & Chief Medical OfficerPuneet Souda - Senior MD - Life Science Tools & DiagnosticsDoug Schenkel - MD - Life Science Tools & DiagnosticsTycho Peterson - MD - Global EquitiesConference Call ParticipantsDaniel Brennan - MD & Senior Equity Research AnalystCatherine Schulte - Senior Research A ...

Natera (NTRA) Q2 2025 Earnings Call August 07, 2025 04:30 PM ET Speaker0Hello. Welcome to Natera's twenty twenty five Second Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. Following management's prepared remarks, we will hold a question and answer session. As a reminder, this conference call is being recorded today, 08/07/2025.I would now like to turn the conference call over to Michael Brophy, Chief Financial Officer. Please go ahead.Speaker1Thanks, ope ...

Natera, Inc. Q2'2025 Earnings Presentation 2 Q2 2025 highlights and recent business updates August 7, 2025 Safe harbor statement This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our market opportunity, our anticipated products and launch schedules, our reimbursement coverage and our product costs, our commercia ...